loader
Please Wait
Applying Filters...

Looking for Tablet Orally Disintegrating Finished Formulations containing CELLULOSE MICROCRYSTALLINE? Find Microcrystalline Cellulose based pharmaceutical excipients on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ALAVERT

02 1ALPRAZOLAM

03 1ARICEPT ODT

04 1ARIPIPRAZOLE

05 2CARBIDOPA AND LEVODOPA

06 1CHILDRENS ALLEGRA ALLERGY

07 1CHILDRENS ALLEGRA HIVES

08 1CLONAZEPAM

09 1CLOZAPINE

10 1FAZACLO ODT

11 1MAXALT-MLT

12 1METOCLOPRAMIDE HYDROCHLORIDE

13 3MIRTAZAPINE

14 10OLANZAPINE

15 4ONDANSETRON

16 1REMERON SOLTAB

17 2RISPERIDONE

18 6RIZATRIPTAN BENZOATE

19 1ZOFRAN ODT

20 3ZOLMITRIPTAN

21 1ZOMIG-ZMT

22 1ZYPREXA ZYDIS

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
FNCE 2024
Not Confirmed

02

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

OLANZAPINE

Drug : ZYPREXA ZYDIS

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 21086

Country : US

Patented : No

blank

03

arrow
FNCE 2024
Not Confirmed

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

ZOLMITRIPTAN

Drug : ZOLMITRIPTAN

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 202560

Country : US

Patented : No

blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

RIZATRIPTAN BENZOATE

Drug : RIZATRIPTAN BENZOATE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 201914

Country : US

Patented : No

blank

06

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

ONDANSETRON

Drug : ONDANSETRON

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78152

Country : US

Patented : No

blank

07

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 208146

Country : US

Patented : No

blank

08

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

CLOZAPINE

Drug : FAZACLO ODT

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 21590

Country : US

Patented : No

blank

09

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

CARBIDOPA; LEVODOPA

Drug : CARBIDOPA AND LEVODOPA

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78893

Country : US

Patented : No

blank

10

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

RIZATRIPTAN BENZOATE

Drug : RIZATRIPTAN BENZOATE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 207835

Country : US

Patented : No

blank